🕵️ Quince Therapeutics, Inc. ($QNCX)
SEC insider & ownership activity, last 12 months · CIK 1662774 · every row links its SEC filing
Over the last 12 months insiders sold $174K with no open-market buying against it. Luca Benatti sold $174K in discretionary trades (Dec). One red-flag 8-K in the window: Delisting notice (3.01), Mar 16, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $174K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Luca Benatti | 0 | – | 1 | $174K | Dec 26, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Group One Trading LLC | 10.7% | 13G | Mar 5, 2026 | filing ↗ | |
| Nantahala Capital Management, LLC | 7.5% | 13G | May 15, 2026 | filing ↗ | |
| Wilmot B. Harkey | 7.5% | 13G | May 15, 2026 | filing ↗ | |
| Daniel Mack | 7.5% | 13G | May 15, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 7.2% | 13G | Jun 10, 2026 | filing ↗ | |
| Millennium Management LLC | 7.2% | 13G | Jun 10, 2026 | filing ↗ | |
| Millennium Group Management LLC | 7.2% | 13G | Jun 10, 2026 | filing ↗ | |
| Israel A. Englander | 7.2% | 13G | Jun 10, 2026 | filing ↗ | |
| Sofinnova Partners SAS, A French Corporation | 5.4% | 13G | Feb 14, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Luca Benatti | $173K | Dec 26, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material Modifications to Rights of Security Holders (3.03) | Jun 26, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jun 26, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | May 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 17, 2026 | filing ↗ |
| Material agreement (1.01) | May 17, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | May 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 17, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 17, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 22, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Apr 9, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 9, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 16, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Other events (8.01) | Feb 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 30, 2026 | filing ↗ |
| Other events (8.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |